Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trial

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 8f1e71b55e93fa32-LAX IP: 116.62.10.13 UTC time: 2024-12-14T13:12:12+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

View original article

GYNECOLOGIC ONCOLOGY

Like

分享书签

0 0 0 0 0 0 0

More from this channel

Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trial

留言 (0)